NCT02471352
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,779 public trials
501 recruiting studies
Neuroendocrine Tumors trial results
NCT07115043
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
- Locations
-
- Research Site Grand Rapids, Michigan, United States
- Research Site St Louis, Missouri, United States
- Research Site Pittsburgh, Pennsylvania, United States
- Research Site Houston, Texas, United States
Recruiting
The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma
NCT07565285
- Conditions
- Melanoma, Melanoma Stage III, Neoplasms, +10 more
- Locations
-
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Gallipoli Medical Research Greenslopes, Queensland, Australia
- Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT07636785
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +49 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
NCT05155033
- Conditions
- Adenocarcinoma, Advanced Locoregional Melanoma, Carcinoma, +26 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06246916
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Ironwood Cancer & Research Centers Chandler, Arizona, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT06298734
- Conditions
- Advanced Melanoma, Melanoma, Melanoma (Skin), +12 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03454035
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Recruiting
Natural History of Familial Carcinoid Tumor
NCT00646022
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +8 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
NCT07718243
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, United Kingdom
- The Royal Marsden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom